August 29, 2014, SANG Guowei, the former vice-chairman of the National People's Congress Standing Committee visited HEC R&D Center, accompanied by deputy mayor of Dongguan, Yu Lijun. The goal of the trip was to investigate and collect suggestion and advices for Significant Innovation Drug Special Project for China’s 13th Five-Year Plan.
th Five-Year Plan. At last, he sincerely hoped that HEC could make great contribution to the development of China's pharmaceutical industry. The Research group visited HEC R&D Center and made known the R&D of biomedicine industry. SANG Guowei complimented the strength of innovation and development of HEC and wish HEC could follow the development trends of international and domestic pharmaceuticals, continue to strengthen innovation-driven strategy, actively participate in the Significant Innovation Drug Special Project for China’s 13
. HEC Pharm was founded in 2002, which is one of the famous pharmaceutical enterprises with the best R&D strength in China. HEC pharm have one of the most outstanding pipelines on 5 therapeutic areas in China: hepatitis, oncology, cardiovascular, diabetes, and neurology. A developed technology platform was established for new molecule, generics and bio-similar in HEC. A group of medicines have been launched in China, US and EU. Nowadays, HEC has turned out to be a leading pharmaceutical company in innovative and globalization in China
Copyright HEC Pharma Co., Ltd license key:粤ICP备19111996号